CK
BMY icon

Carnick & Kubik’s Bristol-Myers Squibb BMY Stock Holding History

Carnick & Kubik’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$261K Hold
4,087
– – 0.08% 295
2015
Q4 		$281K Hold
4,087
– – 0.18% 116
2015
Q3 		$242K Buy
+4,087
New +$259K 0.17% 134
2014
Q1 		– Sell
-1,050
Closed -$55.8K – 121
2013
Q4 		$55.8K Buy
+1,050
New +$53.5K 0.05% 127

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Carnick & Kubik's BMY Position: Q1 2016 in Review

Carnick & Kubik held its Bristol-Myers Squibb (BMY) position steady in Q1 2016 at 4,087 shares worth $261K. The position accounts for 0.08% of the portfolio, ranked #295.

Carnick & Kubik first reported a position in BMY in Q4 2013 and has held it in 4 quarters since. The position peaked at $281K in Q4 2015. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

  • Carnick & Kubik held 4,087 shares of Bristol-Myers Squibb worth $261K as of Q1 2016.
  • Carnick & Kubik left its Bristol-Myers Squibb share count unchanged in Q1 2016.
  • Bristol-Myers Squibb made up 0.08% of Carnick & Kubik's portfolio in Q1 2016, its #295 holding.
  • Carnick & Kubik first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 4 quarters since.
  • Carnick & Kubik's Bristol-Myers Squibb position peaked at $281K in Q4 2015.
  • 1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.